CEO Unlikely to Impact Canopy's Focus on Cannabis-Infused Products and Attractive Exposure to U.S.
Canopy Growth grows and sells cannabis products primarily in Canada, which accounts for roughly 90% of gross sales, with the remainder coming from global markets.Although historically focused on medical cannabis in Canada, Canopy has pivoted to recreational sales after legalization in 2018. Recreational cannabis now accounts for roughly 70% of gross sales. Although we expect the medical market to shrink because of recreational legalization, we forecast roughly 20% average annual growth for the e...Canopy Growth is a licensed producer of medical marijuana in Canada. The principal activities of Co. are the production and sale of marijuana out of its facility in Smiths Falls, Ontario as regulated by the "Marijuana for Medical Purposes Regulations".
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.